Derivatives of 1,4-substituted 6-morpholin-4-yl-1H-pyrazolo [3,4-d] pyrimidine as phosphoinositide-3-kinase (PI3K) inhibitors for the treatment of allergies and asthma

• 收藏
• 分享

专利权人:

Merck Patent GmbH

发明人:

BUCHSTALLER, Hans-Peter,EMDE, Ulrich,KLEIN, Markus,ESDAR, Christina,BOMKE, Joerg

申请号：

ES10757576

公开号：

ES2644221T3

申请日:

2010.09.24

申请国别(地区):

ES

年份:

2017

代理人:

摘要：

Compounds of the formula (I), in which X, R1 and R2 have the meanings indicated in claim 1, are PI3K inhibitors and can be employed, inter alia, for the treatment of autoimmune diseases, inflammation, cardiovascular diseases, neurodegenerative diseases and tumors.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/